AstraZeneca, Teva Settle Heartburn Drug Patent Suits

By Jocelyn Allison

Law360, New York (January 07, 2010, 6:11 PM ET) -- AstraZeneca AB and Teva Pharmaceuticals Ltd. have settled patent litigation over the Israeli generic-drug maker's versions of blockbuster heartburn medications Nexium and Prilosec, according to the companies.

The deals will allow Teva to continue to market its generic version of Prilosec in the U.S. and to start offering generic Nexium in May 2014, according to separate statements from the companies issued Thursday.

The Nexium agreement will settle litigation pending in the U.S. District Court for the District of New Jersey, where AstraZeneca sued Teva after it...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles